3D Tissue Mimicking Biophantoms for Ultrasound Imaging: … · Tamer Mohamed Dr. Konrad Walus Prof....

26
3D Tissue Mimicking Biophantoms for Ultrasound Imaging: Bioprinting and Image Analysis Shekoofeh Azizi, Sharareh Bayat, Ajay Rajaram, Emran M. A. Anas, Tamer Mohamed, Konrad Walus, Purang Abolmaesumi, and Parvin Mousavi

Transcript of 3D Tissue Mimicking Biophantoms for Ultrasound Imaging: … · Tamer Mohamed Dr. Konrad Walus Prof....

3D Tissue Mimicking Biophantoms

for Ultrasound Imaging:

Bioprinting and Image Analysis

Shekoofeh Azizi, Sharareh Bayat, Ajay Rajaram, Emran M. A. Anas,

Tamer Mohamed, Konrad Walus, Purang Abolmaesumi, and Parvin Mousavi

Ultrasound Imaging: Technology

2

1950’s Now ?

3

Past Today Future

Ultrasound Imaging: Experimental Material

4

• 3D printed phantoms with wall-less vessels:

[Desjardins’16] 3D printed phantoms with wall-less vessels, Ultrasound in Medicine

Ultrasound Imaging: Experimental Material

5

3D printed mold that corresponds MRI slices to the pathology ones.

• Ultrasound Tomosynthesis:

[Boctor’16] Ultrasound Tomosynthesis, MICCAI

Ultrasound Imaging: Experimental Material

6

• Ablation Monitoring:

[Imani’15] Ablation monitoring, IEEE TBME

Ultrasound Imaging: Experimental Material

7

• Breast seed implant:

[Fenster’17] 3D ultrasound for breast seed implantation, SPIE

Ultrasound Imaging: Experimental Material

3D-Printing of Phantoms

8

3D printing of optical phantoms simulating heterogeneous biological tissue [Wang’14] Application: Optical calibration Based on 3D biological data

Use of 3D printed materials as tissue-equivalent phantoms [Kalim’15] Application: Radiotherapy dosimetry Model of human lung

kidney phantoms for internal radiation dosimetry [Tran-Gia’16]

Application: SPEC/CT Imaging

In vivo Ultrasound and Photoacoustic Monitoring of Mesenchymal Stem Cells Labeled with Gold Nanotracers [Emelianov’12]

Ultrasound Imaging: Research

9

Agar phantoms in vivo human models in vitro, ex vivo, and animal models

?

10

Objective: 3D Printed Tissue Phantoms

• Controlled tissue parameters, including: • Elasticity

• Scatterer Density

• Scatterer Type

• Tissue phantoms are alive

Conventional 3D Bioprinting

• Materials prepared in advance • Single function printing • Each material requires separate

syringe • Low throughput

11

“Black and white” bioprinting!

Aspect’s Lab-on-a-PrinterTM

12

“Full color

spectrum”

bioprinting!

• Bio-ink combinations generated on-the-fly, deposited from a single nozzle

• Multifunctional microfluidic printhead

• Control over cellular microenvironment • Cell content and ECM content • Growth factors • Bioactive compounds • Stiffness, fiber diameter and architecture

• Rapid fabrication and scale-up potential

• Fabricate heterogeneous tissues with physiological function

Courtesy of Aspect Biosystems Ltd.

Courtesy of Aspect Biosystems Ltd.

Method

15

Biophantom Tissue printing

Ultrasound Imaging ROI selection and Image Analysis

Tissue Characterization

[Fleppa’09, Moradi’09, Azizi’16]

Temporal Enhanced Ultrasound (TeUS)

S. Azizi et al. 16

Cancer

Benign

S. Azizi, et al., “US-based detection of PCa using automatic feature selection with deep belief networks,” MICCAI 2015.

Feature Learning

Classification

Deep Learning

Temporal Enhanced Ultrasound (TeUS)

17 S. Azizi, et al., “US-based detection of PCa using automatic feature selection with deep belief networks,” MICCAI 2015.

0

50

100

150

200

TeUS MRI

Nu

mb

er

of

Co

rce

s

Incorrect Prediction

Correct Prediction

Train: RF TeUS data from 84 biopsy cores.

Test: RF TeUS Data from 171 biopsy cores.

Courtesy of Aspect Biosystems Ltd.

Samples

19

Normal cells Human aortic smooth muscle cells [T/G HA-VSMC]

Cancer cells Human hepatocellular carcinoma cell [HEPG2]

We also printed a third phantom type with no cells

Data Acquisition

20

ROI Selection

21

Depth = 4cm Focal Point = 2 cm

ROI size: 1×1 mm2

Imaging Setting for analysis:

Depth = 4cm Focal Point = 2 cm Frequency: 6.6 MHz FPS: 51 Hz

Feature: mean (Fourier Mag. RF time series data)

Number of Samples:

Benign, cancer and no-cell. Two samples from each category. For each sample, we have acquired RF data at 4 different planes.

Results

22

Cancer Likelihood Colormaps

23

No cell Benign Cancer

Conclusion

• Recent advancements in 3D printing have paved the way for creating large live ultrasound phantoms.

• Controlled experiments can be performed on various cancer cells.

• Human tissue on demand.

24

Thanks!

Shekoofeh Azizi Dr. Sharareh Bayat

Dr. Ajay Rajaram Dr. Emran M. A. Anas

Tamer Mohamed Dr. Konrad Walus

Prof. Purang Abolmaesumi Prof. Parvin Mousavi

26